FDAnews Device Daily Bulletin

Pepex Biomedical Announces Business Updates

Feb. 11, 2013
A A
Pepex Biomedical announced it will enter the mHealth arena by incorporating Machine-to-Machine (M2M) network capabilities in all of its diagnostic medical devices reflecting the company's confidence in the underlying proprietary technology. Pepex will begin with the Trio line of blood glucose devices; it sees M2M as an ideal wireless diabetes care solution that can bridge the current generation of smartphone-based health apps to become a true wireless monitoring solution for diabetes.
Virtual-Strategy Magazine